Apr 16 |
Exelixis to Release First Quarter 2024 Financial Results on Tuesday, April 30, 2024
|
Apr 11 |
Exelixis slips as Barclays downgrades on lack of catalysts
|
Mar 28 |
Exelixis: Patent Woes And Challenging Market Dynamics Make For A Testy 2024
|
Mar 28 |
Insiders Are Dumping These 10 Healthcare Stocks
|
Mar 23 |
4 Magnificent Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market
|
Mar 21 |
Exelixis, Inc.'s (NASDAQ:EXEL) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
|
Mar 17 |
30 Biggest Biotechnology Companies in the World
|
Mar 13 |
Why Is Immunovant, Inc. (IMVT) Down 14.7% Since Last Earnings Report?
|
Mar 11 |
The Zacks Analyst Blog Highlights Legend Biotech, Exact Sciences, Exelixis, Ascendis Pharma and MorphoSys
|
Mar 8 |
10 Biotech Stocks with Huge Potential
|